Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC. Yang JC et al.N Engl J Med. 2025 Sep 7. Epu…

この記事を読む
一臨床医の勉強のための備忘録です。間違いなどあればご指摘を頂ければ幸いです。
この記事を読む
Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC. Yang JC et al.N Engl J Med. 2025 Sep 7. Epu…
この記事を読む
Adagrasib versus docetaxel in KRAS G12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase…
この記事を読む
Pooled analysis of trastuzumab deruxtecan retreatment after recovery from grade 1 interstitial lung disease/pneumonitis.…
この記事を読む
Outcomes and Toxicity following 3 or More Definitive Courses of Thoracic Radiation Therapy for Non-Small Cell Lung Cance…
この記事を読む
Randomized Phase Ⅲ Study of EGFR Tyrosine Kinase Inhibitor and Intercalated Platinum-Doublet Chemotherapy for Non-Small …
この記事を読む
Prospective investigation of biomarker and resistance mechanism using longitudinal cell-free NGS in non-small cell lung …
この記事を読む
Efficacy of first-line treatments for advanced pulmonary sarcomatoid carcinomas: a real-world analysis. Amrane KESMO Ope…
この記事を読む
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer. Forde PM et al.N Engl J Med. 2025 Jun 2. E…
この記事を読む
Gut Microbiota in Advanced NSCLC Receiving Chemoimmunotherapy: An Ancillary Biomarker Study From the Phase Ⅲ Trial JCOG2…
この記事を読む
Durvalumab after concurrent chemoradiotherapy for sensitizing epidermal growth factor receptor-mutant stage III non-smal…